Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check3 days agoChange DetectedThe page footer revision label updated from v3.5.4 to v3.5.5, indicating a newer site revision.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision identifier updated from v3.5.3 to v3.5.4, indicating a newer version of the page was published. This change represents an internal update to page metadata and QA checks, not a substantive change to study content.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s footer revision/version label was updated from v3.5.2 to v3.5.3, indicating a software/release update without changing the displayed study details.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded Cutaneous neuroendocrine carcinoma as a related term and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center. These changes expand contextual references but do not modify the study’s core details, eligibility criteria, outcomes, or locations.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.